This was a fun week if, like me, you enjoy reading about ERISA and insurance issues. There was a lot to pay attention to, but for purposes of this weekly post, I narrowed it down to articles on nuclear verdicts, cyber insurance, regulatory initiatives targeted at PBMs and drug pricing, the continued boom in ERISA